UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K/A
(Amendment No. 1)

Current Report
 
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 21, 2014
 
HIGH PERFORMANCE BEVERAGES COMPANY

(Exact name of registrant as specified in its charter)
 
Nevada
 
000-54973
 
27-3566307
(State of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
5137 E. Armor St., Cave Creek, AZ 85331

   (Address of principal executive offices) (Zip code)
 
(602) 326-8290

   (Registrant's telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
EXPLANATORY NOTE:
 
High Performance Beverages Company, a Nevada corporation, (the “Company”) is furnishing this Current Report on Form 8-K/A in order to amend the previously filed Current Report on Form 8-K dated March 24, 2014. This Form 8-K/A, Amendment No. 1 is being furnished to revise the disclosure under Item 4.02 “Non-Reliance on Previously Issued Financial Statements of an Audit Related Report or Completed Interim Review” to provide additional information as required by Item 4.02 of Form 8-K.
 
Item 4.02       Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
 
On March 21, 2014, in the process of preparing its quarterly report on Form 10-Q for the quarter ended January 31, 2014, the Company’s management became aware that the Company’s financial statements in the annual report for the year ended July 31, 2012 erroneously did not give effect to shareholder advances for the payment of accounting fees and improperly treated shares issued for services as a liability as opposed to equity.  In addition, the Company determined that during the fiscal year ended July 31, 2013, it had (1) erroneously excluded from the derivative liability valuation a contract entered into late in the fiscal year that allowed for the settlement of the Company’s financial obligations under the contract in the Company’s common stock, based upon the price of the Company’s stock at the time of settlement; and, (2) excluded the value of common stock to be issued for services performed from the financial statements resulting in an understatement of compensation expense.  Accordingly, the Company’s management determined that the financial statements included in the annual reports for the years ended July 31, 2012 and 2013 cannot be relied on and instructed the Company’s Chief Financial Officer to restate such financial statements and file amendments to such financial statements as soon as practicable.
 
The Company’s Board of Directors, as well as its management have discussed the matters in this Current Report on Form 8-K with L.L. Bradford & Company, LLC, the Company’s independent public registered accounting firm.

The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2013:

   
Previously
Reported
   
Adjustments
   
Current
Restatement
 
Assets
                 
Current assets
 
 
   
 
       
  Cash
  $ 23,960     $ -     $ 23,960  
  Accounts receivable, net
    -       -       -  
  Inventory
    33,766       -       33,766  
  Deferred loan costs
    26,747       -       26,747  
                         
  Total current assets
    84,473       -       84,473  
  Total assets
  $ 84,473     $ -     $ 84,473  
                         
Liabilities
                       
Accrued expenses
  $ 111,467     $ 16,417     $ 127,884  
Senior secured convertible note payable
    402,800       -       402,800  
Derivative Liability
    452,912       687,585       1,140,497  
Total current liabilities
    967,179       704,200       1,671,181  
                         
Total liabilities
    967,179       704,200       1,671,181  
                         
Stockholders' deficit:
                       
Common stock
    121,408       (5,000 )     116,408  
Stock subscription payable
    315,600       (61,361 )     254,239  
Additional paid in capital
    2,488,564       100,722       2,589,286  
Retained earnings from discontinued operations
    6,944       -       6,944  
Accumulated deficit
    (3,815,222 )     (738,363 )     (4,553,585 )
Total stockholders' deficit
    (882,706 )     (704,002 )     (1,586,708 )
                         
Total liabilities and stockholders' deficit
  $ 84,473     $ -     $ 84,473  
 
 
1

 
 
 
 
 
Previously
 Reported
 
 
Adjustments
 
 
Current
Restatement
 
Statement of Operations
                 
Revenue
 
$
373
 
 
$
-
 
 
$
373
 
Cost of goods sold
 
 
1,392
 
 
 
-
 
 
 
1,392
 
Gross profit
 
 
(1,019
)
 
 
-
 
 
 
(1,019
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
 
 
General, administrative and other
 
 
77,606
 
 
 
4
 
 
 
77,610
 
Marketing
 
 
10,847
 
 
 
(1
)
 
 
10,846
 
Compensation
 
 
983,292
 
 
 
-
 
 
 
983,292
 
                         
Total Operating Expenses
 
 
 1,071,745
 
 
 
3
 
 
 
1,071,748
 
                         
Loss from continuing operations
 
 
(1,072,764
)
 
 
(3
)
 
 
(1,072,767
)
                         
Other income (expense)
 
 
 
 
 
 
 
 
 
 
 
 
Change in derivative liability
 
 
210,482
 
 
 
687,585
 
 
 
898,067
 
Interest expense
 
 
209,268
 
 
 
-
 
 
 
209,268
 
                         
Total Other (Income) Expense
 
 
419,750
 
 
 
 687,585
 
 
 
 1,107,335
 
                         
Net loss
 
$
(1,492,514
)
 
$
(687,588
)
 
$
(2,180,102
)
                         
Net loss per common share
 
$
(0.00
)
 
$
(0.02
)
 
$
(0.02
)
 
The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2013:
 
   
Previously 
Reported
   
Adjustments
   
Current
Restatement
 
Assets
                 
Current assets
 
 
   
 
   
 
 
  Cash
  $ 3,920     $ -     $ 3,920  
  Accounts receivable, net
    -       -       -  
  Inventory
    31,034       -       31,034  
  Deferred loan costs
    174,857       -       174,857  
                         
Total current assets
    209,811       -       209,811  
Total assets
  $ 209,811     $ -     $ 209,811  
                         
Liabilities and Stockholders’ Deficit
                       
                         
Liabilities:
                       
Accrued expenses
  $ 60,564     $ 16,415     $ 76,979  
Convertible notes payable, net
    270,000       -       270,000  
Derivative liability
    242,430       -       242,430  
                         
Total current liabilities
    572,994       16,415       589,409  
Total liabilities
    572,994       16,415       589,409  
                         
Stockholders' deficit:
                       
Common stock
    108,970       (5,000 )     103,970  
Stock subscription payable
    282,220       (61,381 )     220,839  
Additional paid in capital
    1,561,409       100,723       1,662,132  
Retained earnings from discontinued operations
    6,944       -       6,944  
Accumulated deficit
    (2,322,706 )     (50,777 )     (2,373,483 )
Total stockholders' deficit
    (363,183 )     (16,415 )     (379,598 )
Total liabilities and stockholders' deficit
  $ 209,811     $ -     $ 209,811  
 
 
2

 
 
 
 
Previously
 Reported
 
 
Adjustments
 
 
Current
Restatement
 
Statement of Operations
                 
Revenues
 
$
55,143
 
 
$
-
 
 
$
55,143
 
Cost of goods sold
 
 
36,411
 
 
 
-
 
 
 
36,411
 
Gross profit
 
 
18,732
 
 
 
-
 
 
 
18,732
 
                         
Operating expenses
 
 
 
 
 
 
 
 
 
 
 
 
General, administrative and other
 
 
502,162
 
 
 
(220
)
 
 
501,942
 
Marketing
 
 
982,637
 
 
 
-
 
 
 
982,637
 
Product development
 
 
37,077
 
 
 
-
 
 
 
37,077
 
Compensation
 
 
313,007
 
 
 
50,997
 
 
 
364,004
 
                         
Total Operating Expenses
 
 
1,834,886
 
 
 
 50,777
 
 
 
 1,885,660
 
                         
Other expense
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
120,329
 
 
 
-
 
 
 
120,329
 
Change in derivative liability
 
 
242,430
 
 
 
-
 
 
 
242,430
 
                         
Loss from continuing operations
 
 
(2,178,910
)
 
 
(50,777
)
 
 
(2,229,687
)
                         
Discontinued operations, net
 
 
-
 
 
 
-
 
 
 
-
 
                         
Net loss
 
$
(2,178,910
)
 
$
(50,777
)
 
$
(2,229,687
)
                         
Net loss per common share
 
$
(0.02
)
 
$
(0.00
)
 
$
(0.02
)
 
The following tables summarize the effect of corrections on the consolidated financial statements as of the nine months ended April 30, 2013:

   
Previously
Reported
   
Adjustments
   
Current
Restatement
 
Assets
                 
Current assets
 
 
   
 
       
  Cash
  $ 39,015     $ -     $ 39,015  
  Prepaid expenses
    37,042       -       37,042  
  Inventory
    26,587       -       26,587  
  Deferred loan costs
    316,977       -       316,977  
Total current assets
    419,621       -       419,621  
Total assets
  $ 419,621     $ -     $ 419,621  
                         
Liabilities:
                       
Accrued expenses
  $ 44,463     $ 16,415     $ 60,878  
Senior secured convertible note payable
    240,000       -       240,000  
Total current liabilities
    288,463       16,415       300,878  
Derivative liability
    118,133       -       118,133  
                         
Total liabilities
    402,596       16,415       419,011  
                         
Stockholders' deficit: Common stock
    103,970       -       103,970  
Stock subscription payable
    282,220       (61,361 )     220,859  
Additional paid in capital
    1,568,130       95,723       1,663,853  
Retained earnings from discontinued operations
    6,944       -       6,944  
Accumulated deficit
    (1,944,239 )     (50,777 )     (1,995,016 )
Total stockholders' deficit
    17,025       (16,415 )     610  
                         
Total liabilities and stockholders' deficit
  $ 419,621     $ -     $ 419,621  
 
 
3

 
 
Statement of Operations

 
 
Previously
Reported
 
 
Adjustments
 
 
Current
Restatement
 
                         
Revenues
 
$
53,283
 
 
$
-
 
 
$
53,283
 
Cost of goods sold
 
 
35,499
 
 
 
-
 
 
 
35,499
 
Gross Profit                         
Operating expenses
 
 
 17,784
 
 
 
 -
 
 
 
17,784
 
General, administrative and other
 
 
368,094
 
 
 
-
 
 
 
368,094
 
Marketing
 
 
970,379
 
 
 
-
 
 
 
970,379
 
Product development
 
 
37,019
 
 
 
-
 
 
 
37,019
 
Compensation
 
 
300,001
 
 
 
50,777
 
 
 
351,778
 
Total Operating Expenses
 
 
1,676,493
 
 
 
50,777
 
 
 
1,727,270
 
                         
Other income (expense)
 
 
 
 
 
 
 
 
 
 
 
 
  Interest expense and finance costs
 
 
(23,601
)
 
 
-
 
 
 
(23,601
)
  Change in derivative liability
 
 
(118,133
)
 
 
-
 
 
 
(118,133
)
                         
Loss from continuing operations
 
 
(1,785,231
)
 
 
(50,777
)
 
 
1,851,220
)
                         
Discontinued operations, net
 
 
-
 
 
 
-
 
 
 
-
 
                         
Net loss
 
$
(1,785,231
)
 
$
(50,777
)
 
$
(1,851,220
)
                         
Net loss per common share
 
$
(0.00
)
 
$
(0.02
)
 
$
(0.02
)
 
The following tables summarize the effect of corrections on the consolidated financial statements as of the six months ended January 31, 2013:
 
   
Previously
Reported
   
Adjustments
   
Current
Restatement
 
Assets
                 
Current assets
 
 
   
 
       
  Cash
  $ 2,529     $ -     $ 2,529  
  Prepaid expenses
    10,861       -       10,861  
  Inventory
    53,377       -       53,377  
  Deferred loan costs
    452,221       -       452,221  
Total current assets
    518,988       -       518,988  
Total assets
  $ 518,988     $ -     $ 518,988  
                         
Liabilities:
                       
Accrued expenses
  $ 21,748     $ 32,830     $ 54,578  
Senior secured convertible note payable
    100,000       -       100,000  
Total current liabilities
    121,748       32,830       154,578  
                         
Total liabilities
    121,748       32,830       154,578  
                         
Stockholders' deficit: Common stock
    97,560       -       94,150  
Stock subscription payable
    510,000       (61,361 )     448,639  
Additional paid in capital
    645,242       44,946       690,188  
Retained earnings from discontinued operations
    6,944       -       6,944  
Accumulated deficit
    (862,506 )     (16,415 )     (878,921 )
Total stockholders' deficit
    397,420       (32,830 )     364,410  
                         
Total liabilities and stockholders' deficit
  $ 518,988     $ -     $ 518,988  
 
 
4

 
 
Statement of Operations
 
   
Previously
 Reported
   
Adjustments
   
Current
Restatement
 
Revenue
 
$
-
   
$
-
   
$
-
 
Operating expenses
                       
General, administrative and other
   
175,673
     
-
     
175,673
 
Marketing
   
183,129
     
-
     
183,129
 
Product development
   
37,019
     
-
     
37,019
 
Compensation
   
314,500
     
-
     
314,500
 
Total Operating Expenses
   
710,321
     
-
     
710,321
 
Other income (expense)
                       
Interest expense and finance costs
   
(8,389
)
           
(8,389
)
                         
Loss from continuing operations
   
(718,710
)
   
 -
     
(718,710
)
                         
Discontinued operations, net
   
-
     
-
     
-
 
                         
Net loss
 
$
(718,710
)
 
$
-
   
$
(718,710
)
                         
Net loss per common share
 
$
(0.00
)
 
$
(0.00
)
 
$
(0.00
)

The following tables summarize the effect of corrections on the consolidated financial statements as of the three months ended October 31, 2012:
 
 
 
Previously
 Reported
   
Adjustments
   
Current
Restatement
 
 Assets                  
Current assets:
                 
Cash
 
$
2,234
   
$
2,234
   
$
2,234
 
Total current assets
   
2,234
     
2,234
     
2,234
 
Total assets
 
$
2,234
   
$
2,234
   
$
2,234
 
Liabilities:
                       
Accrued expenses
 
$
9,539
   
$
16,415
   
$
25,954
 
Total current liabilities
   
9,539
     
16,415
     
25,954
 
Liability for Issuable Common Stock
   
203,361
     
(203,361
)
   
-
 
                         
Total liabilities
   
 212,900
     
(186,946
)
   
 25,954
 
                         
Stockholders' deficit: Common stock
   
  94,150
     
  -
     
  94,150
 
Additional paid in capital
   
(22,709
)
   
44,946
     
22,237
 
Stock subscription payable
   
-
     
142,000
     
142,000
 
Retained earnings from discontinued operations
   
6,944
     
-
     
6,944
 
Accumulated deficit
   
(289,051
)
   
-
     
(289,051
)
Total stockholders' deficit
   
(210,666
)
   
186,946
     
(23,720
)
                         
Total liabilities and stockholders' deficit
 
$
2,234
   
$
-
   
$
2,234
 
 
 
5

 

Statement of Operations
 
   
Previously
Reported
   
Adjustments
   
Current
Restatement
 
Revenue
 
$
-
   
$
-
   
$
-
 
                         
Operating expenses
                       
General, administrative and other
   
53,380
     
-
     
53,380
 
Marketing
   
43,131
     
-
     
43,131
 
Product development
   
21,744
     
-
     
21,744
 
Compensation
   
27,000
     
-
     
27,000
 
Total Operating Expenses
   
145,255
     
-
     
145,255
 
                         
Loss from continuing operations
   
(145,255
)
   
 -
     
(145,255
)
                         
Discontinued operations, net
   
-
     
-
     
-
 
                         
Net loss
 
$
(145,255
)
 
$
-
   
$
(145,255
)
                         
Net loss per common share
 
$
(0.00
)
 
$
(0.00
)
 
$
(0.00
)

The following tables summarize the effect of corrections on the consolidated financial statements as of the year ended July 31, 2012:
 
 
 
Previously
 Reported
   
Adjustments
   
Current
Restatement
 
 Assets                  
Assets
 
$
-
   
$
-
   
$
-
 
Total assets
 
$
-
   
$
-
   
$
-
 
Liabilities:
                       
Accrued expenses
 
$
4,050
   
$
32,830
   
$
36,880
 
Total current liabilities
   
4,050
     
32,830
     
36,880
 
                         
Liability for Issuable Common Stock
   
61,361
     
(61,361
)
   
-
 
                         
Total liabilities
   
 65,411
     
(28,531
)
   
 36,880
 
                         
Stockholders' deficit: Common stock
   
  94,150
     
  -
     
  94,150
 
Additional paid in capital
   
(22,709
)
   
44,946
     
22,237
 
Retained earnings from discontinued operations
   
6,944
             
6,944
 
Accumulated deficit
   
(143,796
)
   
(16,415
)
   
(160,211
)
Total stockholders' deficit
   
(65,411
)
   
(28,531
)
   
(36,880
)
                         
Total liabilities and stockholders' deficit
 
$
-
   
$
-
   
$
-
 
 
 
6

 
 
Statement of Operations
 
   
Previously
 Reported
   
Adjustments
   
Current
Restatement
 
Revenue
 
 -
   
$
 -
   
$
-
 
                         
Operating expenses
                       
General, administrative and other
   
49,820
     
16,415
     
66,235
 
Marketing
   
5,863
     
-
     
5,863
 
Product development
   
45,413
     
-
     
45,413
 
Compensation
   
20,000
     
-
     
20,000
 
Total Operating Expenses
   
121,096
     
16,415
     
137,511
 
                         
Loss from continuing operations
   
(121,096
)
   
 16,415
     
(137,511
)
                         
Discontinued operations, net
   
(25
)
   
-
     
(25
)
                         
Net loss
 
$
(121,121
)
 
$
16,415
   
$
(137,536
)
                         
Net loss per common share
 
$
(0.00
)
 
$
(0.00
)
 
$
(0.00
)
 
 
7

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
HIGH PERFORMANCE BEVERAGES COMPANY
     
Dated: April 25, 2014
By:
/s/ Toby McBride
   
Name: Toby McBride
   
Title: Chief Executive Officer